257 related articles for article (PubMed ID: 10393381)
1. Growth factors in continuous ambulatory peritoneal dialysis effluent. Their relation with peritoneal transport of small solutes.
Lai KN; Lai KB; Szeto CC; Lam CW; Leung JC
Am J Nephrol; 1999; 19(3):416-22. PubMed ID: 10393381
[TBL] [Abstract][Full Text] [Related]
2. Growth factors VEGF and TGF-beta1 in peritoneal dialysis.
Zweers MM; de Waart DR; Smit W; Struijk DG; Krediet RT
J Lab Clin Med; 1999 Aug; 134(2):124-32. PubMed ID: 10444025
[TBL] [Abstract][Full Text] [Related]
3. A simple assessment of peritoneal transport in stable continuous ambulatory peritoneal dialysis patients.
Lai KN; Szeto CC; Ho KK; Yu AW; Mak TW; Lam CW
Am J Nephrol; 1998; 18(4):311-7. PubMed ID: 9653835
[TBL] [Abstract][Full Text] [Related]
4. Persistent transforming growth factor-beta 1 expression may predict peritoneal fibrosis in CAPD patients with frequent peritonitis occurrence.
Lin CY; Chen WP; Yang LY; Chen A; Huang TP
Am J Nephrol; 1998; 18(6):513-9. PubMed ID: 9845827
[TBL] [Abstract][Full Text] [Related]
5. Dialysate cell population and cancer antigen 125 in stable continuous ambulatory peritoneal dialysis patients: their relationship with transport parameters.
Lai KN; Lai KB; Szeto CC; Ho KK; Poon P; Lam CW; Leung JC
Am J Kidney Dis; 1997 May; 29(5):699-705. PubMed ID: 9159303
[TBL] [Abstract][Full Text] [Related]
6. Intraperitoneal interleukin-6 levels predict peritoneal solute transport rate: a prospective cohort study.
Yang X; Zhang H; Hang Y; Yan H; Lin A; Huang J; Ni Z; Qian J; Fang W
Am J Nephrol; 2014; 39(6):459-65. PubMed ID: 24854010
[TBL] [Abstract][Full Text] [Related]
7. Longitudinal study of peritoneal membrane function in continuous ambulatory peritoneal dialysis: relationship with peritonitis and fibrosing factors.
Wong TY; Szeto CC; Lai KB; Lam CW; Lai KN; Li PK
Perit Dial Int; 2000; 20(6):679-85. PubMed ID: 11216559
[TBL] [Abstract][Full Text] [Related]
8. Relationship of peritoneal membrane transport characteristics to the nutritional status in CAPD patients.
Kang DH; Yoon KI; Choi KB; Lee R; Lee HY; Han DS; Cho EY; Lee JH
Nephrol Dial Transplant; 1999 Jul; 14(7):1715-22. PubMed ID: 10435882
[TBL] [Abstract][Full Text] [Related]
9. Persistent transforming growth factor beta 1 expression may predict peritoneal fibrosis in CAPD patients with frequent peritonitis occurrence.
Lin CY; Chen WP; Fu LW; Yang LY; Huang TP
Adv Perit Dial; 1997; 13():64-71. PubMed ID: 9360653
[TBL] [Abstract][Full Text] [Related]
10. Connective tissue growth factor (CTGF/CCN2) is increased in peritoneal dialysis patients with high peritoneal solute transport rate.
Mizutani M; Ito Y; Mizuno M; Nishimura H; Suzuki Y; Hattori R; Matsukawa Y; Imai M; Oliver N; Goldschmeding R; Aten J; Krediet RT; Yuzawa Y; Matsuo S
Am J Physiol Renal Physiol; 2010 Mar; 298(3):F721-33. PubMed ID: 20015945
[TBL] [Abstract][Full Text] [Related]
11. Selected growth factors in peritoneal dialysis: their relationship to markers of inflammation, dialysis adequacy, residual renal function, and peritoneal membrane transport.
Stompór T; Zdzienicka A; Motyka M; Dembińska-Kieć A; Davies SJ; Sulowicz W
Perit Dial Int; 2002; 22(6):670-6. PubMed ID: 12556068
[TBL] [Abstract][Full Text] [Related]
12. The relationship between peritoneal transport characteristics and messenger RNA expression of aquaporin in the peritoneal dialysis effluent of CAPD patients.
Szeto CC; Lai KB; Chow KM; Szeto CY; Li PK
J Nephrol; 2005; 18(2):197-203. PubMed ID: 15931648
[TBL] [Abstract][Full Text] [Related]
13. Dialysate to plasma solute concentration (D/P) versus peritoneal transport parameters in CAPD.
Heimbürger O; Waniewski J; Werynski A; Park MS; Lindholm B
Nephrol Dial Transplant; 1994; 9(1):47-59. PubMed ID: 8177476
[TBL] [Abstract][Full Text] [Related]
14. Correlation between peritoneal mesothelial cell cytology and peritoneal histopathology with respect to prognosis in patients on continuous ambulatory peritoneal dialysis.
Izumotani T; Ishimura E; Yamamoto T; Otoshi T; Okuno S; Inaba M; Kim M; Nishizawa Y
Nephron; 2001 Sep; 89(1):43-9. PubMed ID: 11528231
[TBL] [Abstract][Full Text] [Related]
15. Changes of cytokine profiles during peritonitis in patients on continuous ambulatory peritoneal dialysis.
Lai KN; Lai KB; Lam CW; Chan TM; Li FK; Leung JC
Am J Kidney Dis; 2000 Apr; 35(4):644-52. PubMed ID: 10739785
[TBL] [Abstract][Full Text] [Related]
16. Nitrate in stable CAPD patients and during peritonitis.
Douma CE; de Waart DR; Zemel D; Imholz AL; Koomen GC; Struijk DG; Krediet RT
Adv Perit Dial; 1995; 11():36-40. PubMed ID: 8534733
[TBL] [Abstract][Full Text] [Related]
17. Peritoneal transport status influence on atherosclerosis/inflammation in CAPD patients.
Sezer S; Tutal E; Arat Z; Akçay A; Celik H; Ozdemir FN; Haberal M
J Ren Nutr; 2005 Oct; 15(4):427-34. PubMed ID: 16198934
[TBL] [Abstract][Full Text] [Related]
18. Longitudinal change in peritoneal membrane function with continuous ambulatory peritoneal dialysis (CAPD) after peritonitis episodes.
Chen JB; Pan HH; Lee CH; Chien YS; Lee CT; Liu TT; Lam KK; Hsu KT
Chang Gung Med J; 2004 Jan; 27(1):29-34. PubMed ID: 15074887
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of peritoneal transport and membrane status in peritoneal dialysis: focus on incident fast transporters.
Rodrigues AS; Martins M; Korevaar JC; Silva S; Oliveira JC; Cabrita A; Castro e Melo J; Krediet RT
Am J Nephrol; 2007; 27(1):84-91. PubMed ID: 17284895
[TBL] [Abstract][Full Text] [Related]
20. Increased levels of transforming growth factor beta 1 and basic fibroblast growth factor in patients on CAPD: a study during non-infected steady state and peritonitis.
Mlambo NC; Hylander B; Brauner A
Inflammation; 1999 Apr; 23(2):131-9. PubMed ID: 10213269
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
